Anti-Covid-19 N protein mAb IgM(06FC)
Product Specifications
Background
Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways . Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool. COVID-19 antibodies can be produced by a host immune system following exposure to SARS-CoV-2. IgG and IgM antibodies are also known as immunoglobulins IgG and IgM, respectively, and are among the antibody isotypes produced by vertebrate immune systems.
CAS Number
9007-83-4
Synonyms
SARS-CoV-2 Nucleoprotein , 2019-nCoV Nucleoprotein, Covid-19 Nucleoprotein
Host
Mouse
Reactivity
Covid-19
Immunogen
The recombinant SARS-CoV-2 (2019-nCoV) N Protein
Clonality
Monoclonal
Applications
WB,ELISA
Stability
-20°C for 1 year
Concentration
0.1ug/mL
Antibody Type
Secondary antibody
Isotype
IgM
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog